Titrated Disease Management for Patients With Hypertension



Status:Completed
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/13/2019
Start Date:July 27, 2012
End Date:October 31, 2016

Use our guide to learn which trials are right for you!

Randomized Trial of Titrated Disease Management for Patients With Hypertension

This randomized clinical trial examines whether programs aimed at matching resources to
patient hypertension (i.e. high blood pressure) control lead to greater reduction in systolic
blood pressure (top number of blood pressure reading) than simply having maintenance phone
calls in addition to usual care. Answering this question will provide important evidence
concerning the overall goal of sustained long-term implementation of the disease management
programs as part of patient aligned care teams in the Veterans Affairs and other healthcare
systems.

Project Objectives: The investigators are conducting a two-arm 18-month randomized clinical
trial for patients with pharmaceutically treated hypertension for which systolic BP is not
controlled (>/=140 mmHg for non-diabetic or >/=130 mmHg for diabetic patients). The primary
aim will be to compare two treatment arms/strategies in terms of impact on systolic BP
control: Arm 1 - An intervention arm using titrated disease management in which patients'
hypertension control, assessed at baseline, 6 and 12 months, will be used to decide the
resource intensity of strategies: 1) Medium/level 1 resource intensity strategy: a registered
nurse will provide monthly tailored behavioral support telephone calls + home BP monitoring;
2) High/level 2 resource intensity strategy: a pharmacist will provide monthly tailored
behavioral support telephone calls + home BP monitoring + pharmacist-directed medication
management; and 3) Booster (low) resource intensity strategy: a license practice nurse (LPN)
will provide bi-monthly, non-tailored behavioral support telephone calls to patients whose
systolic BP comes under control. Arm 2 - A control arm, in which an LPN will provide
bi-monthly non-tailored behavioral support telephone calls (same procedures as the booster
(low) resource intensity strategy component of the titrated intervention).

Inclusion Criteria:

- Age >= 18 years.

- Assigned primary care provider in one of the clinics of the Durham VA Medical Center
(VAMC) (including Community Based Outpatient Clinics for example - Hillandale Clinic
and Greenville (CBOC)).

- Had at least 1 primary care visit at the Durham VA or affiliated CBOC in the last
year.

- Diagnosis of hypertension requiring medication, as determined by: ICD 401.0, 401.1, or
401.9 for >= 2 outpatient encounters during the prior year and Received a prescription
for at least 1 of the following classes of hypertensive medication in the previous
year: 1) ACE inhibitors; 2) alpha blockers; 3) angiogenesis II inhibitors; 4) beta
blockers; 5) calcium channel blockers; 6) diuretics; 7) antihypertensive combination;
and/or 8) antihypertensives, other.

- Out of control systolic blood pressure: Durham VAMC (including CBOCs or other
affiliated clinics captured in the Durham VAMC electronic health record) outpatient BP
measurements >= 150 mmHg for non-diabetic or >= 140 mmHg for diabetic patients over
the last year and last systolic BP measurement >= 140 mmHg for non-diabetic or >= 130
mmHg for diabetic patients. If additional patients need to be approached to be offered
the opportunity for further screening, non-diabetic patients with mean outpatient
systolic BP of >= 140 mmHg or diabetic patients with mean outpatient systolic BP of >=
130 mmHg over the past year may be approached.

Patients must indicate that they both:

- Have a VA or affiliated clinic provider that they consider to be their main PCP.

- Receive the majority of healthcare at the Durham VA Medical Center (or affiliated
clinic - such as Hillandale or Greenville).

Exclusion Criteria:

- Active diagnosis of psychosis.

- Diagnosis of metastatic cancer.

- Type 1 diabetes

- Class IV congestive heart failure (CHF).

- Currently receiving kidney dialysis or if estimated glomerular filtration rate (eGFR)
levels are <= 15.

- Chronic obstructive pulmonary disease (COPD) requiring oxygen.

- Resident in nursing home or receiving home healthcare.

- Patient is pregnant or reports planning to become pregnant in the next two years

- At the time of potential enrollment, participating in another ongoing hypertension,
diabetes, cholesterol, or cardiovascular disease clinical trial.

- Planning to leave the area prior to the anticipated end of participation.

- Inability or unwillingness to come to the Durham VAMC or affiliated clinic such as
Hillandale or Greenville for baseline-, 6-, 12-, and 18-month study visits.

- Does not have reasonable access to a telephone.

- Does not speak English.

- Severely impaired hearing or speech (Patients must be able to respond to phone
calls.).

- Severely impaired vision (Patients must be able to read mailed material).

- Refusal or inability to provide informed consent and HIPAA authorization form.

- Arm size > 50 cm

- Unable to obtain (including by arm) valid blood pressure readings

- Inadequate mental status to complete the protocol, as judged by five or more errors on
the Short Portable Mental Status Questionnaire (SPMSQ).

- Former, current or pending solid organ or bone marrow transplant patient.
We found this trial at
1
site
Durham, North Carolina 27705
?
mi
from
Durham, NC
Click here to add this to my saved trials